Journal article
Gestation-specific vital sign reference ranges in pregnancy
- Abstract:
-
Objective:
To estimate normal ranges for maternal vital signs throughout pregnancy, which have not been well defined in a large contemporary population.
Methods:
We conducted a three-center, prospective, longitudinal cohort study in the United Kingdom from August 2012 to September 2017. We recruited women at less than 20 weeks of gestation without significant comorbidities with accurately dated singleton pregnancies. We measured participants' blood pressure (BP), heart rate, respiratory rate, oxygen saturation and temperature following standardized operating procedures at 4–6 weekly intervals throughout pregnancy.
Results:
We screened 4,279 pregnant women, 1,041 met eligibility criteria and chose to take part. Systolic and diastolic BP decreased slightly from 12 weeks of gestation: median or 50th centile (3rd–97th centile) 114 (95–138); 70 (56–87) mm Hg to reach minimums of 113 (95–136); 69 (55–86) mm Hg at 18.6 and 19.2 weeks of gestation, respectively, a change (95% CI) of −1.0 (−2 to 0); −1 (−2 to −1) mm Hg. Systolic and diastolic BP then rose to a maximum median (3rd–97th centile) of 121 (102–144); 78 (62–95) mm Hg at 40 weeks of gestation, a difference (95% CI) of 7 (6–9) and9 (8–10) mm Hg, respectively. The median (3rd–97th centile) heart rate was lowest at 12 weeks of gestation: 82 (63–105) beats per minute (bpm), rising progressively to a maximum of 91 (68–115) bpm at 34.1 weeks. SpO2 decreased from 12 weeks of gestation: median (3rd–97th centile) 98% (94–99%) to 97% (93–99%) at 40 weeks. The median (3rd–97th centile) respiratory rate at 12 weeks of gestation was 15 (9–22), which did not change with gestation. The median (3rd–97th centile) temperature at 12 weeks of gestation was 36.7 (35.6–37.5)°C, decreasing to a minimum of 36.5 (35.3–37.3)°C at 33.4 weeks.
Conclusion:
We present widely relevant, gestation-specific reference ranges for detecting abnormal BP, heart rate, respiratory rate, oxygen saturation and temperature during pregnancy. Our findings refute the existence of a clinically significant BP drop from 12 weeks of gestation.
Clinical Trial Registration:
ISRCTN, ISRCTN10838017.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, 826.3KB, Terms of use)
-
- Publisher copy:
- 10.1097/AOG.0000000000003721
Authors
- Publisher:
- Lippincott, Williams and Wilkins
- Journal:
- Obstetrics and Gynecology More from this journal
- Volume:
- 135
- Issue:
- 3
- Pages:
- 653-664
- Publication date:
- 2020-02-06
- Acceptance date:
- 2019-12-12
- DOI:
- EISSN:
-
1873-233X
- ISSN:
-
0029-7844
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:1080104
- UUID:
-
uuid:5d673fd7-b17a-42a2-881f-67bdf450fede
- Local pid:
-
pubs:1080104
- Source identifiers:
-
1080104
- Deposit date:
-
2019-12-28
Terms of use
- Copyright holder:
- Green et al.
- Copyright date:
- 2020
- Rights statement:
- Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American College of Obstetricians and Gynecologists. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record